Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I E Smith

Showing results (141-150 of 371) with videos related to

Pageof 38
Sort By:
Scandinavian Journal of Immunology|May 16, 2013
Inhibitors of BTK and ITK: state of the new drugs for cancer, autoimmunity and inflammatory diseasesL Vargas, A Hamasy, B F Nore, et al.
Oncology (Williston Park, N.Y.)|December 1, 2000
UFT/leucovorin plus bolus epirubicin and cyclophosphamide in advanced/metastatic breast cancerR K Gregory, S R Johnston, I E Smith, et al.
Journal of Substance Abuse Treatment|January 1, 1992
A comparison study of treated and untreated pregnant and postpartum cocaine-abusing womenI E Smith, D Z Dent, C D Coles, et al.
British Journal of Cancer|May 1, 1983
Endocrine effects of low dose aminoglutethimide alone in advanced postmenopausal breast cancerA L Harris, M Dowsett, I E Smith, et al.
Cancer Research|February 1, 1978
In vitro radiation response of cells from four human tumors propagated in immune-suppressed miceI E Smith, V D Courtenay, J Mills, et al.
Breast (Edinburgh, Scotland)|October 13, 2015
Long-term outcome of HER2 positive metastatic breast cancer patients treated with first-line trastuzumabB Yeo, K Kotsori, K Mohammed, et al.
Cancer Treatment Reports|October 1, 1978
Vindesine: a phase II study in the treatment of breast carcinoma, malignant melanoma, and other tumorsI E Smith, D W Hedley, T J Powles, et al.
British Journal of Cancer|January 1, 1983
Pentamethylmelamine (PMM): Phase I clinical and pharmacokinetic studiesJ R Muindi, D R Newell, I E Smith, et al.
British Journal of Cancer|March 1, 1992
In vitro effects of substance P analogue [D-Arg1, D-Phe5, D-Trp7,9, Leu11] substance P on human tumour and normal cell growthM J Everard, V M Macaulay, J L Miller, et al.
British Journal of Cancer|January 1, 1984
Prevention of acute deaths in mice after very high dose cyclophosphamide by divided dose scheduleB D Evans, I E Smith, R D Clutterbuck, et al.
Pageof 38

Showing results (141-150 of 371) with videos related to

Sort By:
Pageof 38
Scandinavian Journal of Immunology|May 16, 2013
Inhibitors of BTK and ITK: state of the new drugs for cancer, autoimmunity and inflammatory diseasesL Vargas, A Hamasy, B F Nore, et al.
Oncology (Williston Park, N.Y.)|December 1, 2000
UFT/leucovorin plus bolus epirubicin and cyclophosphamide in advanced/metastatic breast cancerR K Gregory, S R Johnston, I E Smith, et al.
Journal of Substance Abuse Treatment|January 1, 1992
A comparison study of treated and untreated pregnant and postpartum cocaine-abusing womenI E Smith, D Z Dent, C D Coles, et al.
British Journal of Cancer|May 1, 1983
Endocrine effects of low dose aminoglutethimide alone in advanced postmenopausal breast cancerA L Harris, M Dowsett, I E Smith, et al.
Cancer Research|February 1, 1978
In vitro radiation response of cells from four human tumors propagated in immune-suppressed miceI E Smith, V D Courtenay, J Mills, et al.
Breast (Edinburgh, Scotland)|October 13, 2015
Long-term outcome of HER2 positive metastatic breast cancer patients treated with first-line trastuzumabB Yeo, K Kotsori, K Mohammed, et al.
Cancer Treatment Reports|October 1, 1978
Vindesine: a phase II study in the treatment of breast carcinoma, malignant melanoma, and other tumorsI E Smith, D W Hedley, T J Powles, et al.
British Journal of Cancer|January 1, 1983
Pentamethylmelamine (PMM): Phase I clinical and pharmacokinetic studiesJ R Muindi, D R Newell, I E Smith, et al.
British Journal of Cancer|March 1, 1992
In vitro effects of substance P analogue [D-Arg1, D-Phe5, D-Trp7,9, Leu11] substance P on human tumour and normal cell growthM J Everard, V M Macaulay, J L Miller, et al.
British Journal of Cancer|January 1, 1984
Prevention of acute deaths in mice after very high dose cyclophosphamide by divided dose scheduleB D Evans, I E Smith, R D Clutterbuck, et al.
Pageof 38